Lakefront BiotherapeuticsLKFT
28.11
+0.60
(+2.18%)
收盤 06/05 03:57 (UTC+8)
06/05 03:57 (UTC+8)
Lakefront BiotherapeuticsLKFT
28.11
+0.60
(+2.18%)
財務數據
損益表
- 1.22
- -
- -
- 0.75
- 0.65
- 0.71
- 9.01
- 0.06
- -
- -
- -
- -
- -12.92
- 9.00
- 1165.89
- -99.28
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2012/Q4 | |
營業收入淨額 | 6,481 | 900,822 | 71,161 | 65,288 | 74,977 | - | - | 121,592 |
營業成本 | 4,799 | 455 | 10,846 | 4,706 | 13,729 | - | - | 7,362 |
營業毛利 | 1,682 | 900,367 | 60,315 | 60,582 | 61,248 | - | - | 114,230 |
營業費用 | 65,385 | 141,569 | 101,987 | 117,609 | 219,956 | - | - | 126,789 |
研發費用 | 30,962 | 107,512 | 73,882 | 95,275 | 182,752 | - | - | 105,814 |
推銷及管理費用 | 35,505 | 2,943 | 46,423 | 18,797 | 43,797 | - | - | 17,671 |
非經常性項目費用 | - | - | - | - | - | - | - | 3,304 |
其他營業費用 | -1,082 | 21,628 | -18,029 | 3,248 | -6,593 | - | - | - |
營業利益 | -63,703 | 758,798 | -41,672 | -57,027 | -158,708 | - | - | -12,559 |
其他收入及費用 | - | - | - | - | - | - | - | 2,541 |
利息費用 | - | - | - | - | - | 97 | 695 | - |
稅前純益 | 13,956 | 783,155 | -221,493 | -104,424 | -156,367 | - | - | -10,019 |
所得稅 | 70 | 666 | -17,499 | 26 | -1,814 | - | - | -216 |
稅後純益 | 14,492 | 782,146 | -202,111 | -105,748 | -153,403 | - | - | -7,543 |
基本每股稅後盈餘(元) | 0.22 | - | - | - | -2.33 | - | - | - |
稀釋每股稅後盈餘(元) | 0.22 | - | - | - | -2.33 | - | - | - |
基本平均股數(千股) | 65872.00 | - | - | - | 65838.00 | - | - | - |
稀釋平均股數(千股) | 65872.00 | - | - | - | 65838.00 | - | - | - |
還原基本每股稅後盈餘(元) | 0.22 | - | - | - | -2.33 | - | - | - |
還原稀釋每股稅後盈餘(元) | 0.22 | - | - | - | -2.33 | - | - | - |
還原基本平均股數(千股) | 65,872 | - | - | - | 65,838 | - | - | - |
還原稀釋平均股數(千股) | 65,872 | - | - | - | 65,838 | - | - | - |
EBITDA(千元) | 14,562 | 782,812 | -219,610 | -105,722 | -155,217 | 97 | 695 | 4,119 |